Sun.Dec 15, 2024

article thumbnail

Bernoulli equation for Doppler pressure gradient

All About Cardiovascular System and Disorders

Bernoulli equation for calculation of pressure gradient by Doppler echocardiography is: A: P=2V 2 B: P=3V 2 C: P=4V 2 D: P=4V 3 Correct answer: C: P=4V 2 Original Bernoulli equation is a complex equation. This is a simplified equation routinely used in Doppler echocardiography for pressure gradient across valves while quantifying severity of stenosis.

article thumbnail

The FDA Hasn't Inspected This Drug Factory After 7 Recalls for the Same Flaw

Med Page Today

(MedPage Today) -- ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. The drug potassium chloride has been on the market for decades, widely prescribed.

105
105
article thumbnail

Machine-Learning Models Could Help ID MASH Patients Considered Candidates for Resmetirom

HCPLive

Machine learning models improve accuracy in detecting MASH with F2-F3 fibrosis, surpassing noninvasive tests in sensitivity, specificity, and predictive value.

105
105
article thumbnail

Been drinking and your heart's fluttering? You may have 'holiday heart'

Medical Xpress - Cardiology

It's the time of year for workplace Christmas parties, and gatherings with family and friends. Maybe you'll drink a lot in one go.

87
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis

HCPLive

Matthew J. Budoff, MD describes bridging the gap between atherosclerosis and osteoporosis through advanced Imaging techniques.

article thumbnail

The Grinch’s Guide to Women’s Heart Attacks (with apologies to Dr. Seuss)

Heart Sisters

"Your tests all look fine!" (No one quite knows the reason). You're probably just feeling stressed by the season!

More Trending

article thumbnail

Targeting macrophage–fibroblast interactions in the failing heart

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 16 December 2024; doi:10.1038/s41569-024-01112-z Macrophagefibroblast interactions have a central role in cardiac fibrosis. In response to left ventricular pressure overload, CCR2+ cardiac macrophages acquire a fibrogenic phenotype, secreting IL-1 and promoting the activation of a FAP+ POSTN+ fibroblast subpopulation through the transcription factor MEOX1.

article thumbnail

Study Highlights Real-World Morality Rates, Factors Increasing Mortality Risk in MASH

HCPLive

Real-world data from 18,710 MASH patients highlight the impact of comorbidities, biomarkers, and region on mortality, with 70% of deaths CVD-related.

article thumbnail

Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE study

HeartRhythm

There is a large variability in the management of conduction disturbances (CDs) after transcatheter aortic valve replacement (TAVR).

article thumbnail

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS‐MI)

European Journal of Heart Failure

Abstract Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardial infarction (MI) are considered to be at risk of progressive adverse cardiac remodelling which can lead to the development of heart failure and death. The early addition of a sodiumglucose cotransporter 2 (SGLT2) inhibitor to standard treatment may delay or prevent progressive adverse remodelling in these patients.

article thumbnail

Pentaspline catheter or cryoballoon for pulmonary vein plus posterior wall isolation in persistent atrial fibrillation: 1-Year outcomes

HeartRhythm

Left atrial posterior wall isolation (LAPWI) plus pulmonary vein isolation (PVI) can be performed with radiofrequency ablation, cryoballoon ablation (CB-A), or, recently, pulsed field ablation (PFA).

article thumbnail

Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON‐HF

European Journal of Heart Failure

A summary of effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum. All participants in PARAGON-HF were divided into three age groups: <65years, 6574years, and75years. Compared to younger participants, older participants had worse clinical outcomes ( A ), derived similar benefits from sacubitril/valsartan ( B ), despite being more likely to develop hypotension when randomized to sacubitril/valsartan ( C ).

article thumbnail

A novel focal lattice-tip catheter toggling between pulsed field energy and radiofrequency for atrial arrhythmia ablation: Results from a real-world, multicenter registry

HeartRhythm

A novel focal lattice-tip catheter allowing the delivery of either pulsed field (PF) or radiofrequency (RF) energy has recently received regulatory approval. The technology features a proprietary 3-dimensional electroanatomic mapping system.

article thumbnail

Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association’s Scientific Sessions 2024 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2024

Circulation

Circulation, Volume 150, Issue 25 , Page e712-e763, December 17, 2024.

article thumbnail

Addressing Known hypertensive disOrders of pregnancy in woMen of African descent in Canada (AKOMA): protocol for a mixed method study

Frontiers in Cardiovascular Medicine

BackgroundHypertensive disorders of pregnancy (HDP) predispose a woman to maternity-related cardiovascular morbidity and mortality. However, there is limited literature on HDP among women of African descent in Canada.Methods and designA convergent mixed-method study will be used to investigate the intersection of self-reported HDP risks in women of African descent in Canada with a history of a HDP (quantitative, cross-sectional survey) and explore the perception and experiences of women of Afric

article thumbnail

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high‐, middle‐ and low‐income countries – A Global Congestive Heart Failure (G‐CHF) study

European Journal of Heart Failure

Abstract Aims The aim of this study was to describe the prognostic importance of left ventricular ejection fraction (LVEF) versus right ventricular (RV) dilatation and dysfunction in patients with heart failure (HF) from countries of different income levels. Methods and results We enrolled 17321 participants with HF from 40 countries. Participants were followed for a median (25th75th percentile) of 2.1 (2.04.6)years.

article thumbnail

A new prediction model for sustained ventricular tachycardia in arrhythmogenic cardiomyopathy

Frontiers in Cardiovascular Medicine

BackgroundArrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by high risks of sustained ventricular tachycardia (sVT) and sudden cardiac death. Identifying patients with high risk of sVT is crucial for the management of ACM.MethodsA total of 147 ACM patients were retrospectively enrolled in the observational study and divided into training and validation groups.

article thumbnail

Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review

Frontiers in Cardiovascular Medicine

Coronary artery disease (CAD)cardiovascular condition occuring due to atherosclerotic plaque accumulation in the epicardial arteriesis responsible for disabilities of millions of people worldwide and remains the most common single cause of death. Inflammation is the primary pathological mechanism underlying CAD, since is involved in atherosclerotic plaque formation.

article thumbnail

Case Report: Avoiding misdiagnosis in amyloidosis—navigating transthyretin genopositivity and monoclonal gammopathy in a patient with advanced heart failure and spinal stenosis

Frontiers in Cardiovascular Medicine

BackgroundA 63-year-old Black woman presented with progressive exertional dyspnea and chronic lower back pain. The course and findings in her case are instructive.Case reportFamily history was notable for cardiac deaths. An echocardiogram demonstrated ventricular wall thickening with diastolic dysfunction. The patients N-terminal pro b-type natriuretic peptide level was 1,691pg/ml with a troponin I level of 0.36ng/ml.

article thumbnail

Differences in severity of diffuse and focal coronary stenosis between visual and quantitative assessment

Frontiers in Cardiovascular Medicine

BackgroundCoronary Artery Disease (CAD) is a leading cause of mortality, with an increasing number of patients affected by coronary artery stenosis each year. Coronary angiography (CAG) is commonly employed as the definitive diagnostic tool for identifying coronary artery stenosis. Physician Visual Assessment (PVA) is often used as the primary method to determine the need for further intervention, but its subjective nature poses challenges.

article thumbnail

Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Frontiers in Cardiovascular Medicine

Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely understood. Retrospective analysis of NSCLC patients with 1 echocardiogram post-osimertinib between 2007 and 2022 was performed.

Cancer 52
article thumbnail

Cardiac function in pregnant women with preeclampsia

Frontiers in Cardiovascular Medicine

IntroductionPreeclampsia (PE) is thought to be the consequence of impaired placental perfusion leading to placental hypoxia. While it has been demonstrated that PE may be a consequence of maternal cardiovascular maladaptation, the exact role of maternal cardiac function remains to be determined. This study sought to assess cardiac characteristics in pregnant women diagnosed with PE and to determine the possible relationship between PE, maternal cardiac changes/function, and NT-proBNP levels.Meth

article thumbnail

The impact of atrial voltage and conduction velocity phenotypes on atrial fibrillation recurrence

Frontiers in Cardiovascular Medicine

IntroductionLow atrial voltage and slow conduction velocity (CV) have been associated with atrial fibrillation (AF); however, their interaction and relative importance as early disease markers remain incompletely understood. We aimed to elucidate the relationship between atrial voltage and CV using high-density electroanatomic (HDE) maps of patients with AF.MethodsHDE maps obtained during sinus rhythm in 52 patients with AF and five healthy controls were analysed.